Prognosis and demographic characteristics of SSPE patients in Istanbul, Turkey
- PMID: 25270981
- DOI: 10.1016/j.braindev.2014.09.006
Prognosis and demographic characteristics of SSPE patients in Istanbul, Turkey
Abstract
Aim: SSPE is a rare progressive, invariably fatal long-term complication of measles infection. In this study, we assessed the demographic and prognostic characteristics of 64 consecutive SSPE patients diagnosed at a tertiary center.
Methods: The study had a retrospective design; data were obtained from patient records.
Results: The study includes 64 patients diagnosed with SSPE. There was history of consanguineous marriage in 27 (42.2%) patients. The average patient lifespan was 3.8years (45days-12years). The average patient age at diagnosis was 12.3 (range, 5-17)years. A statistically significant correlation was found between the age at diagnosis and lifespan (p=0.002). A statistically significant correlation was found between the incubation period and patient lifespan (p<0.001). No significant correlation was found between duration in the intensive care unit and lifespan (p=0.122). Routine physical therapy had no significant impact on the average lifespan (p=0.619). No significant difference was found between the vaccination dose and lifespan (p=0.651).
Conclusions: High frequency of parental consanguinity in SSPE patients need to be evaluated as there might a genetic influence. Physical therapy and supportive treatments seems to have no affect on lifespan in SSPE patients. The age at diagnosis and incubation period might have an affect on prognosis and lifespan.
Keywords: Measles; Measles vaccine; SSPE; Survival.
Copyright © 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Subacute sclerosing panencephalitis surveillance study in Istanbul.Brain Dev. 2006 Apr;28(3):183-9. doi: 10.1016/j.braindev.2005.07.004. Epub 2005 Dec 20. Brain Dev. 2006. PMID: 16368215
-
Subacute sclerosing panencephalitis in Bulgaria (1978-2002).Neuroepidemiology. 2004 Sep-Oct;23(5):254-7. doi: 10.1159/000079952. Neuroepidemiology. 2004. PMID: 15316253
-
Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.J Commun Dis. 2009 Sep;41(3):161-7. J Commun Dis. 2009. PMID: 22010482
-
[Epidemiological aspects of SSPE].Nihon Rinsho. 2007 Aug;65(8):1460-5. Nihon Rinsho. 2007. PMID: 17695284 Review. Japanese.
-
[Subacute sclerosing panencephalitis (SSPE)].Nihon Rinsho. 1997 Apr;55(4):908-15. Nihon Rinsho. 1997. PMID: 9103893 Review. Japanese.
Cited by
-
Subacute sclerosing panencephalitis as a re-emerging condition due to low vaccination coverage: a case-series.Ital J Pediatr. 2025 Jun 7;51(1):173. doi: 10.1186/s13052-025-02026-3. Ital J Pediatr. 2025. PMID: 40483442 Free PMC article.
-
Antivirals targeting paramyxovirus membrane fusion.Curr Opin Virol. 2021 Dec;51:34-47. doi: 10.1016/j.coviro.2021.09.003. Epub 2021 Sep 27. Curr Opin Virol. 2021. PMID: 34592709 Free PMC article. Review.
-
Disease-Modifying Therapy in Subacute Sclerosing Panencephalitis: An Area of Darkness.Ann Indian Acad Neurol. 2023 Jan-Feb;26(1):3-9. doi: 10.4103/aian.aian_655_22. Epub 2023 Jan 25. Ann Indian Acad Neurol. 2023. PMID: 37034052 Free PMC article.
-
Subacute sclerosing panencephalitis - current perspectives.Pediatric Health Med Ther. 2018 Jun 26;9:67-71. doi: 10.2147/PHMT.S126293. eCollection 2018. Pediatric Health Med Ther. 2018. PMID: 29985487 Free PMC article. Review.
-
Seizures as onset symptoms and rapid course in preschool children with subacute sclerosing panencephalitis.Brain Behav. 2021 Apr;11(4):e02051. doi: 10.1002/brb3.2051. Epub 2021 Feb 5. Brain Behav. 2021. PMID: 33543580 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources